NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.5401
-0.0186 (-3.33%)
At close: Jun 24, 2026, 4:00 PM EDT
0.5659
+0.0258 (4.78%)
After-hours: Jun 24, 2026, 4:49 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $4.93 million as of June 24, 2026. Its market cap has decreased by -72.93% in one year.
Market Cap
4.93M
Enterprise Value
8.95M
1-Year Change
-72.93%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $4.93M, a decrease of -74.82%. That is a compound annual growth rate of -26.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 4.93M | -62.38% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 35.23M |
| Harvard Bioscience | 27.20M |
| Milestone Scientific | 26.63M |
| Regentis Biomaterials | 22.32M |
| Retractable Technologies | 20.35M |
| Jin Medical International | 19.02M |
| Bionano Genomics | 13.14M |
| Femasys | 12.56M |